Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial

Autor: Pan-gen Cui, XY Yang, H Jia, ZP Guo, JB Wang, XS Chen, Lin Lin, ZG Bi, NZ Lu

Publikováno v: The Journal of dermatological treatment. 13(2)

Herpes simplex facialis/labialis (HSFL) is a common infectious skin disorder, caused mainly by herpes simplex virus (HSV) type 1, for which the topical application of a cream containing an antiviral agent for treatment of the disease has been widely

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2836cb8c6ba36fba092ae394c57d7b
https://pubmed.ncbi.nlm.nih.gov/12060504

Bevacizumab attenuates osteosarcoma angiogenesis by suppressing MIAT encapsulated by serum-derived extracellular vesicles and facilitating miR-613-mediated GPR158 inhibition.

Autor: Wang BD; Department of Orthopedics, the First Affiliated Hospital of Harbin Medical University, Harbin, 150001, P. R. China.; Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Harbin, 150001, P. R. China., Yu XJ; Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, P. R. China., Hou JC; Department of Emergency Surgery, the First Affiliated Hospital of Jiamusi University, Jiamusi, 154000, P. R. China., Fu B; Department of Orthopedics, the First Affiliated Hospital of Harbin Medical University, Harbin, 150001, P. R. China., Zheng H; Department of Orthopedics, the First Affiliated Hospital of Harbin Medical University, Harbin, 150001, P. R. China., Liu QK; Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, P. R. China., Wang SX; Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, P. R. China., Bi ZG; Department of Orthopedics, the First Affiliated Hospital of Harbin Medical University, Harbin, 150001, P. R. China. drbizhenggang@163.com., Cao Y; Department of Orthopedics, the First Affiliated Hospital of Harbin Medical University, Harbin, 150001, P. R. China. caoyang@hrbmu.edu.cn.

Publikováno v: Cell death & disease [Cell Death Dis] 2022 Mar 28; Vol. 13 (3), pp. 272. Date of Electronic Publication: 2022 Mar 28.

[Clinical study of psychological changes and post traumatic stress disorder in elderly patients with hip fracture].

Autor: Fan XM; Department of Orthopaedics, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, China., Bi ZG, Fu CJ, Wang XM, Zou JL, Chen HJ, Li SM, Sun JB

Publikováno v: Zhonghua wai ke za zhi [Chinese journal of surgery] [Zhonghua Wai Ke Za Zhi] 2020 Mar 01; Vol. 58 (3), pp. 209-212.

[Reviewing the surgery strategy for fracture neck of femur].

Autor: Bi ZG; Department of Orthopedics, the First Affiliated Hospital of Harbin Medical University, Harbin 150001,China., Wang XM; Department of Orthopedics, the First Affiliated Hospital of Harbin Medical University, Harbin 150001,China.

Publikováno v: Zhonghua wai ke za zhi [Chinese journal of surgery] [Zhonghua Wai Ke Za Zhi] 2019 Nov 01; Vol. 57 (11), pp. 804-806.

MHY1485 ameliorates UV-induced skin cell damages via activating mTOR-Nrf2 signaling.

Autor: Yang B; Department of Dermatology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Xu QY; Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Guo CY; Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Huang JW; Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Wang SM; Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Li YM; Department of Dermatology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Tu Y; Department of Dermatology, The First Affiliated Hospital of Kunming Medical University, Yunnan Provincial Institute of Dermatology, Kunming, China., He L; Department of Dermatology, The First Affiliated Hospital of Kunming Medical University, Yunnan Provincial Institute of Dermatology, Kunming, China., Bi ZG; Department of Dermatology, BenQ Medical Center, Nanjing Medical University, Nanjing, China., Ji C; Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China., Cheng B; Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Publikováno v: Oncotarget [Oncotarget] 2017 Feb 21; Vol. 8 (8), pp. 12775-12783.